ArticleScientific reports2026

LK-1: an investigational therapy targeting hCG-β in metastatic breast, bladder, ovarian, and cervical cancers.

J Helena Kinion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.